Katie studied biochemistry at the University of Oxford, before joining a lab to investigate why the immune system can’t control HIV. She then worked in science communication for the MS Society and joined Cancer Research UK’s News and Content team in 2017, where she writes for the blog and news feed.
In the news this week: engineered cell therapy given initial ‘no’ for NHS in England and we publish our research highlights in our 2017/18 annual review.
New research has shown that an intelligent knife can distinguish between ovarian cancer and normal tissue. Could it help make ovarian cancer surgery smarter?
Bowel screening age to be dropped to 50 in England and study looks to tackle childhood obesity by coaching new parents.
Cannabis extract was in the news after a study found that combining it with chemo extended the lives of mice with pancreatic cancer.
Scientists are slowly uncovering what makes brain tumours tick. Combining this information with research on the healthy brain could lead to new treatments.
The Government announced that boys will get the HPV vaccine, and severe obesity in 10 and 11-year olds hits record high.
A dye used in brain tumour surgery will be rolled out more widely and an immunotherapy drug for neuroblastoma has been made available on NHS.
New computer simulation study suggests only screening women deemed at a ‘high risk’ of breast cancer could help to reduce unnecessary diagnoses.
This week’s headlines: drug could protect children from hearing loss after chemo and cancer rates in over-75s are ‘set to rocket’.
New trials results show that a drug can reduce hearing loss in children treated with the chemo drug cisplatin. We talk to the lead researcher, Dr Penelope Brock.